Gene · 8215
Papers1,958
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,958
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disease-Specific haptoglobin N-Glycosylation in inflammatory disorders between cancers and benign diseases of 3 types of female internal genital organs. | Clin Chim Acta | 2023 | 37285951 | PubTator, text mining | PubMed |
| Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 37266589 | PubTator, text mining | PubMed |
| Organoid-based single-cell spatiotemporal gene expression landscape of human embryonic development and hematopoiesis. | Signal Transduct Target Ther | 2023 | 37264003 | PubTator, text mining | PubMed |
| Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment. | Front Cell Dev Biol | 2023 | 37255594 | PubTator, text mining | PubMed |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells. | Front Physiol | 2023 | 37250123 | PubTator, text mining | PubMed |
| Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. | Int J Mol Sci | 2023 | 37240338 | PubTator, text mining | PubMed |
| Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target. | Biology (Basel) | 2023 | 37237541 | PubTator, text mining | PubMed |
| Prostate cancer and bone: clinical presentation and molecular mechanisms. | Endocr Relat Cancer | 2023 | 37226936 | PubTator, text mining | PubMed |
| Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt/β-Catenin Signaling Pathway. | Biomolecules | 2023 | 37189394 | PubTator, text mining | PubMed |
| The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation. | Int J Mol Sci | 2023 | 37176077 | PubTator, text mining | PubMed |
| In Vitro Cell Transformation Assays: A Valuable Approach for Carcinogenic Potentiality Assessment of Nanomaterials. | Int J Mol Sci | 2023 | 37175926 | PubTator, text mining | PubMed |
| The regulatory role of alternative splicing in inflammatory bowel disease. | Front Immunol | 2023 | 37153612 | PubTator, text mining | PubMed |
| Receptors that bind to PEDF and their therapeutic roles in retinal diseases. | Front Endocrinol (Lausanne) | 2023 | 37139333 | PubTator, text mining | PubMed |
| Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway. | BMC Neurosci | 2023 | 37127577 | PubTator, text mining | PubMed |
| A review of signal pathway induced by virulent protein CagA of Helicobacter pylori. | Front Cell Infect Microbiol | 2023 | 37124036 | PubTator, text mining | PubMed |
| Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery. | Pharmaceutics | 2023 | 37111603 | PubTator, text mining | PubMed |
| Pituitary Tumorigenesis-Implications for Management. | Medicina (Kaunas) | 2023 | 37109772 | PubTator, text mining | PubMed |
| PGE2 Produced by Exogenous MSCs Promotes Immunoregulation in ARDS Induced by Highly Pathogenic Influenza A through Activation of the Wnt-β-Catenin Signaling Pathway. | Int J Mol Sci | 2023 | 37108459 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | 37108193 | PubTator, text mining | PubMed |
| The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling. | J Cell Biol | 2023 | 37071417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8215/papers?page=10